Quality of Life in Cutaneous T-cell Lymphoma Patients Receiving Mogamulizumab: Important Factors to Consider

SIMPLE SUMMARY: Patients with erythrodermic cutaneous T-cell lymphoma often experience severe symptoms. This study provides an insight into the impact of the disease, mogamulizumab treatment, and essential patient-reported outcomes. The data on patients’ expectation, quality of life, and treatment s...

Descripción completa

Detalles Bibliográficos
Autores principales: Ottevanger, Rosanne, van Beugen, Sylvia, Evers, Andrea W. M., Willemze, Rein, Vermeer, Maarten H., Quint, Koen D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817675/
https://www.ncbi.nlm.nih.gov/pubmed/36612028
http://dx.doi.org/10.3390/cancers15010032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817675/
https://www.ncbi.nlm.nih.gov/pubmed/36612028
http://dx.doi.org/10.3390/cancers15010032

Ejemplares similares